AKT1polymorphisms are associated with risk for metabolic syndrome
โ Scribed by Joseph M. Devaney; Heather Gordish-Dressman; Brennan T. Harmon; Margaret K. Bradbury; Stephanie A. Devaney; Tamara B. Harris; Paul D. Thompson; Priscilla M. Clarkson; Thomas B. Price; Theodore J. Angelopoulos; Paul M. Gordon; Niall M. Moyna; Linda S. Pescatello; Paul S. Visich; Robert F. Zoeller; Richard L. Seip; Jinwook Seo; Bo Hyoung Kim; Laura L. Tosi; Melissa Garcia; Rongling Li; Joseph M. Zmuda; Matthew J. Delmonico; Robert S. Lindsay; Barbara V. Howard; William E. Kraus; Eric P. Hoffman
- Publisher
- Springer
- Year
- 2010
- Tongue
- English
- Weight
- 379 KB
- Volume
- 129
- Category
- Article
- ISSN
- 0340-6717
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract CYP1A1 is likely to play an important role in the etiology of CaP through its function in activating environmental procarcinogens and catalyzing the oxidative metabolites of estrogens. To test the hypothesis that genetic polymorphisms in the __CYP1A1__ gene may be associated with the ri
Flap endonuclease 1 (FEN1) is a key enzyme in maintaining genomic stability and protecting against carcinogenesis. This study investigated whether functional variations in FEN1 gene are associated with DNA damage and lung cancer risk. Thirty DNA samples were sequenced to identify variants and functi
## Abstract Apurinic/apyrimidinic endonuclease 1 (APE1) is a DNA repair protein, which plays important roles in the base excision repair (BER) pathway. Genetic variations of __APE1__ have been shown to influence an individual's susceptibility to carcinogenesis. We hypothesized the genetic polymorph